UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

Nature communications, 2016-03, Vol.7 (1), p.11150-11150, Article 11150

2016

Link zum Volltext

Verfügbarkeit prüfen

Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis

American Journal of Physiology: Cell Physiology, 2015-10, Vol.309 (7), p.C444-C456

2015

Link zum Volltext

Verfügbarkeit prüfen

Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters

Clinical cancer research, 2017-08, Vol.23 (15), p.4473-4481

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

The Journal of clinical investigation, 2018-02, Vol.128 (2), p.589-606

2018

Link zum Volltext

Verfügbarkeit prüfen

Expression of long noncoding RNAs in cancer‐associated fibroblasts linked to patient survival in ovarian cancer

Cancer science, 2020-05, Vol.111 (5), p.1805-1817

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer

PloS one, 2012-01, Vol.7 (1), p.e29079

2012

Link zum Volltext

Verfügbarkeit prüfen

Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance

PloS one, 2013-12, Vol.8 (12), p.e81859

2013

Link zum Volltext

Verfügbarkeit prüfen

FGF18 as a prognostic and therapeutic biomarker in ovarian cancer

The Journal of clinical investigation, 2013-10, Vol.123 (10), p.4435-4448

2013

Link zum Volltext

Verfügbarkeit prüfen

Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer

The Journal of pathology, 2017-06, Vol.242 (2), p.140-151

2017

Link zum Volltext

Verfügbarkeit prüfen

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells

Oncotarget, 2017-03, Vol.8 (10), p.16951-16963

2017

Link zum Volltext

Verfügbarkeit prüfen

ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment

Nature communications, 2020-07, Vol.11 (1), p.3546-16, Article 3546

2020

Link zum Volltext

Verfügbarkeit prüfen

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas

The American journal of pathology, 2010-10, Vol.177 (4), p.1611-1617

2010

Link zum Volltext

Verfügbarkeit prüfen

A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

Cancer cell, 2009-12, Vol.16 (6), p.521-532

2009

Link zum Volltext

Verfügbarkeit prüfen

Microfibril-associated protein 5 and the regulation of skin scar formation

Scientific reports, 2023-05, Vol.13 (1), p.8728-8728

2023

Link zum Volltext

Verfügbarkeit prüfen

Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers

Nature communications, 2019-09, Vol.10 (1), p.4369-12, Article 4369

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Clinical cancer research, 2013-02, Vol.19 (4), p.809-820

2013

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

Nature medicine, 2003-05, Vol.9 (5), p.568-574

2003

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis and Clinical Management of Uterine Serous Carcinoma

Cancers, 2020-03, Vol.12 (3), p.686

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers

PloS one, 2011-07, Vol.6 (7), p.e21121

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (22), p.10602-10612

2005

Link zum Volltext

Verfügbarkeit prüfen

Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes

Journal of experimental & clinical cancer research, 2022-08, Vol.41 (1), p.1-242, Article 242

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses

Cancers, 2024-02, Vol.16 (5), p.846

2024

Link zum Volltext

Verfügbarkeit prüfen

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision

Cancers, 2018-02, Vol.10 (2), p.57

2018

Link zum Volltext

Verfügbarkeit prüfen

Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression

Cancers, 2020-01, Vol.12 (1), p.118

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(275)

Publikationsform

Sprache

Englisch
(294)
Japanisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Life Sciences & Biomedicine
(174)
Humans
(166)
Female
(157)
Oncology
(121)
Ovarian Neoplasms - Genetics
(81)
Tumors
(78)
Biological And Medical Sciences
(76)
Ovarian Neoplasms - Pathology
(71)
Ovarian Cancer
(70)
Medical Sciences
(67)
Gynecology. Andrology. Obstetrics
(57)
Female Genital Diseases
(50)
Ovarian Neoplasms - Metabolism
(48)
Middle Aged
(36)
Obstetrics & Gynecology
(36)
Tumor Cells, Cultured
(33)
Adult
(31)
Cell Line, Tumor
(31)
Gene Expression Regulation, Neoplastic
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(64)
Gynecologic Oncology
(25)
Clinical Cancer Research
(23)
Neoplasia
(13)
Cancers
(11)
Oncogene
(10)
Jnci : Journal Of The National Cancer Institute
(7)
Journal Of Reproductive Medicine
(7)
Molecular Cancer Therapeutics
(7)
Plos One
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis

Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

Expression of long noncoding RNAs in cancer‐associated fibroblasts linked to patient survival in ovarian cancer

Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer

Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance

FGF18 as a prognostic and therapeutic biomarker in ovarian cancer

Mesothelial‐to‐mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells

ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment

BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas

A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

Microfibril-associated protein 5 and the regulation of skin scar formation

Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers

Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

Pathogenesis and Clinical Management of Uterine Serous Carcinoma

Identification of novel therapeutic targets in microdissected clear cell ovarian cancers

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary

Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes

Molecular, Metabolic, and Subcellular Mapping of the Tumor Immune Microenvironment via 3D Targeted and Non-Targeted Multiplex Multi-Omics Analyses

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision

Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression

Suchergebnisse filtern